Internal Medicine, Hematology & Oncology · Skokie, IL
NPI
1336138726
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9711 Skokie Blvd, Ste A
Skokie, IL, 60077
Phone (847) 568-9930
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
590 services
Medicare patients, 2024
153
Average age 76
Drug cost, 2024
$3.7M
1,036 prescriptions
Company payments, 2025
$1,619
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ira A Oliff was code 99232 (hospital e&m - subsequent), 246 times for 84 patients. In total Ira A Oliff billed 590 services in 11 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 246 | 84 | $63.61 | $16K |
| 99231 Hospital E&M - Subsequent | Facility | 143 | 67 | $39.69 | $5,676 |
| 99222 Hospital E&M - Initial | Facility | 125 | 100 | $105.77 | $13K |
| 99214 Office E&M - Established | Facility | 19 | 13 | $70.88 | $1,347 |
| 99214 Office E&M - Established | Office | 16 | 13 | $69.75 | $1,116 |
By year: 2022 $42K for 684 services; 2023 $34K for 497 services; 2024 $40K for 590 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ira A Oliff prescribed most often to Medicare patients was Anastrozole, with 84 prescriptions and refills. In total Ira A Oliff wrote 1,036 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 84 | 204 | 26 | $1,207 |
| Prednisone Generic | 83 | 85 | 23 | $309 |
| Abiraterone Acetate Generic | 50 | 50 | Under 11 | $71K |
| Hydroxyurea Generic | 36 | 72 | Under 11 | $770 |
| Revlimid Lenalidomide | 32 | 32 | Under 11 | $629K |
| Dexamethasone Generic | 32 | 37 | 14 | $474 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 31 | 31 | 13 | $715 |
| Ondansetron Odt Ondansetron | 29 | 29 | 20 | $229 |
| Eliquis Apixaban | 29 | 45 | Under 11 | $25K |
| Imatinib Mesylate Generic | 26 | 26 | Under 11 | $17K |
| Megestrol Acetate Generic | 24 | 27 | Under 11 | $2,905 |
| Brukinsa Zanubrutinib | 23 | 23 | Under 11 | $305K |
| Prochlorperazine Maleate Generic | 22 | 22 | 16 | $243 |
| Xtandi Enzalutamide | 21 | 21 | Under 11 | $302K |
| Mirtazapine Generic | 20 | 24 | Under 11 | $360 |
Brand drugs: - claims; generic drugs: 763 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ira A Oliff $1,619 ($803 in general payments such as food, travel and fees and $817 for research) from 21 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $817.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $817 |
| Janssen Biotech, Inc. JNJ | 5 | $150 |
| GlaxoSmithKline, LLC. GSK | 5 | $124 |
| Daiichi Sankyo Inc. 4568.T | 4 | $105 |
| Pfizer Inc. PFE | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $69.01 |
| SpringWorks Therapeutics, Inc. | 1 | $37.72 |
| PharmaEssentia USA Corporation 6446.TW | 1 | $31.74 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $31.34 |
| Genentech USA, Inc. ROG.SW | 1 | $29.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.